June 5, 2017 / 7:06 AM / 2 months ago

BRIEF-Veloxis and Endo Ventures announce agreement on commercialization in Canada

1 Min Read

June 5 (Reuters) - VELOXIS PHARMACEUTICALS A/S:

* VELOXIS PHARMACEUTICALS A/S AND ENDO VENTURES LIMITED JOINTLY ANNOUNCE AGREEMENT FOR PALADIN LABS INC. TO COMMERCIALIZE ENVARSUS XR® IN CANADA

* ‍VELOXIS WILL RECEIVE AN UP-FRONT PAYMENT AND WILL SUPPLY ENVARSUS XR AT A PRE-SPECIFIED TRANSFER PRICE​

* ‍INITIAL TERM OF AGREEMENT IS 15 YEARS FROM EFFECTIVE DATE OF AGREEMENT.​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below